The table below shows Burning Rock Biotech Ltd's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
-$4.07M
-$12.64M
-$36.03M
-$66.23M
-$74.99M
-$11.27M
Capital expenditure
$751.00K
$742.00K
$1.14M
$8.99M
$32.06M
$9.24M
Investing cash flow
-$628.00K
-$604.00K
-$1.31M
-$1.08M
$12.82M
-$16.75M
Dividends paid
-
-
-
-
BNR operating cash flow (10-K history)
Burning Rock Biotech Ltd reported operating cash flow of -$4.07M for fiscal year 2025. That is up 67.8% from -$12.64M in fiscal 2024. Over the 6 fiscal years shown, operating cash flow grew from -$11.27M (FY 2020) to -$4.07M. Figures come from the company's audited annual reports as filed with the SEC.